PeptiDream Inc., a leading biotechnology company headquartered in Japan, specialises in the discovery and development of peptide-based therapeutics. Founded in 2006, PeptiDream has established itself as a pioneer in the field of peptide drug design, leveraging its proprietary Peptide Discovery Platform System (PDPS) to create unique peptide compounds for various therapeutic applications. With a strong presence in Japan and expanding operations in North America and Europe, PeptiDream focuses on oncology, metabolic diseases, and central nervous system disorders. The company has achieved significant milestones, including collaborations with major pharmaceutical firms, which underscore its market position as a key player in peptide therapeutics. PeptiDream's innovative approach and commitment to advancing peptide-based solutions set it apart in the competitive biotechnology landscape.
How does Peptidream's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Peptidream's score of 32 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2022, PeptiDream Inc., headquartered in Japan, reported a CO₂ emissions figure of approximately 7,720 kg CO2e per employee for Scope 1 and 2 emissions. This reflects a decrease from 9,210 kg CO2e per employee in 2021 and 8,760 kg CO2e per employee in 2020. The company has set ambitious near-term targets to further reduce its greenhouse gas emissions. Specifically, PeptiDream commits to a 50% reduction in absolute Scope 1 and 2 emissions by 2030, using 2023 as the baseline year. Additionally, the company aims to cut its absolute Scope 3 emissions—primarily from purchased goods and services and upstream transportation and distribution—by 25% within the same timeframe. These targets align with the Science Based Targets initiative (SBTi) and are consistent with the reductions necessary to limit global warming to 1.5°C.
Access structured emissions data, company-specific emission factors, and source documents
2020 | |
---|---|
Scope 1 | - |
Scope 2 | 1,381,000 |
Scope 3 | 236,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Peptidream is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.